190 related articles for article (PubMed ID: 12455059)
1. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer.
Hamanaka Y; Suehiro Y; Fukui M; Shikichi K; Imai K; Hinoda Y
Int J Cancer; 2003 Jan; 103(1):97-100. PubMed ID: 12455059
[TBL] [Abstract][Full Text] [Related]
2. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.
von Mensdorff-Pouilly S; Verstraeten AA; Kenemans P; Snijdewint FG; Kok A; Van Kamp GJ; Paul MA; Van Diest PJ; Meijer S; Hilgers J
J Clin Oncol; 2000 Feb; 18(3):574-83. PubMed ID: 10653872
[TBL] [Abstract][Full Text] [Related]
3. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract][Full Text] [Related]
4. Tissue and serum MUC1 mucin detection in breast cancer patients.
Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of MUC1 in advanced pancreatic cancer.
Hinoda Y; Ikematsu Y; Horinochi M; Sato S; Yamamoto K; Nakano T; Fukui M; Suehiro Y; Hamanaka Y; Nishikawa Y; Kida H; Waki S; Oka M; Imai K; Yonezawa S
J Gastroenterol; 2003; 38(12):1162-6. PubMed ID: 14714254
[TBL] [Abstract][Full Text] [Related]
6. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.
Budiu RA; Mantia-Smaldone G; Elishaev E; Chu T; Thaller J; McCabe K; Lenzner D; Edwards RP; Vlad AM
Cancer Immunol Immunother; 2011 Jul; 60(7):975-84. PubMed ID: 21461842
[TBL] [Abstract][Full Text] [Related]
7. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
9. Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer.
Tang Y; Cui X; Xiao H; Qi S; Hu X; Yu Q; Shi G; Zhang X; Gu J; Yu Y; Wang L; Li Y
Mol Med Rep; 2017 May; 15(5):2659-2664. PubMed ID: 28447743
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: relation to survival.
Kurtenkov O; Klaamas K; Mensdorff-Pouilly S; Miljukhina L; Shljapnikova L; Chuzmarov V
Acta Oncol; 2007; 46(3):316-23. PubMed ID: 17450466
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
[TBL] [Abstract][Full Text] [Related]
12. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer.
Hirasawa Y; Kohno N; Yokoyama A; Kondo K; Hiwada K; Miyake M
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):589-94. PubMed ID: 10673204
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancer.
Nakamura H; Hinoda Y; Nakagawa N; Makiguchi Y; Itoh F; Endo T; Imai K
J Gastroenterol; 1998 Jun; 33(3):354-61. PubMed ID: 9658314
[TBL] [Abstract][Full Text] [Related]
14. Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
Oei AL; Moreno M; Verheijen RH; Sweep FC; Thomas CM; Massuger LF; von Mensdorff-Pouilly S
Int J Cancer; 2008 Oct; 123(8):1848-53. PubMed ID: 18661524
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.
Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L
Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819
[TBL] [Abstract][Full Text] [Related]
16. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
[TBL] [Abstract][Full Text] [Related]
18. MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.
Yamamoto K; Ueno T; Kawaoka T; Hazama S; Fukui M; Suehiro Y; Hamanaka Y; Ikematsu Y; Imai K; Oka M; Hinoda Y
Anticancer Res; 2005; 25(5):3575-9. PubMed ID: 16101182
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening.
Laidi F; Bouziane A; Errachid A; Zaoui F
Asian Pac J Cancer Prev; 2016; 17(1):335-9. PubMed ID: 26838233
[TBL] [Abstract][Full Text] [Related]
20. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
